Results for tag: "Ureter Cancer Drug"

The Ureter Cancer Drug market is a subset of the Kidney Cancer Drug market, which is focused on the development of treatments for ureter cancer. Ureter cancer is a rare form of cancer that affects the ureter, the tube that carries urine from the kidney to the bladder. Treatment options for ureter cancer include surgery, chemotherapy, radiation therapy, and targeted therapy. Targeted therapy is a type of treatment that uses drugs to target specific molecules involved in the growth and spread of cancer cells. The Ureter Cancer Drug market is a rapidly growing field, with a number of companies developing new treatments. Companies in the market include AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. These companies are researching and developing new drugs to treat ureter cancer, as well as other forms of kidney cancer. Show Less Read more